P3 Health Partners Inc. Holds Shareholder Vote

TL;DR

P3 Health Partners shareholders voted on company matters on June 6th.

AI Summary

On June 6, 2024, P3 Health Partners Inc. filed an 8-K report detailing a submission of matters to a vote of security holders. The company, incorporated in Delaware, held its annual meeting where shareholders voted on various proposals. The filing does not disclose the specific outcomes of these votes but confirms the event took place.

Why It Matters

This filing indicates a key governance event where shareholders exercised their voting rights, which can influence the company's future direction and management decisions.

Risk Assessment

Risk Level: low — The filing is a routine procedural report about a shareholder vote and does not contain information that inherently increases risk.

Key Players & Entities

• P3 Health Partners Inc. (company) — Registrant
• Delaware (jurisdiction) — State of incorporation
• June 6, 2024 (date) — Date of earliest event reported

FAQ

Key Financial Figures

• $0.0001 — stered Class A common stock, par value $0.0001 per share PIII The Nasdaq Stock Market
• $11.50 — A common stock at an exercise price of $11.50 PIIIW The Nasdaq Stock Market LLC Ind

Filing Documents

• piii-20240606.htm (8-K) — 43KB
• piii-20240606_g1.jpg (GRAPHIC) — 201KB
• 0001628280-24-027325.txt ( ) — 672KB
• piii-20240606.xsd (EX-101.SCH) — 2KB
• piii-20240606_def.xml (EX-101.DEF) — 15KB
• piii-20240606_lab.xml (EX-101.LAB) — 26KB
• piii-20240606_pre.xml (EX-101.PRE) — 16KB
• piii-20240606_htm.xml (XML) — 4KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. On June 6, 2024, P3 Health Partners Inc. (the "Company") held its 2024 Annual Meeting of Stockholders (the "Annual Meeting"). Holders of the Company's Class A common stock and Class V common stock as of the close of business on April 12, 2024, the record date for the Annual Meeting, were each entitled to one vote per share. The following are the voting results for the four proposals considered and voted upon at the Annual Meeting, each of which were described in the Company's Definitive Proxy Statement filed with the Securities and Exchange Commission on April 26, 2024. Proposal 1 — Election of three Class III directors for a term of office expiring on the date of the annual meeting of stockholders to be held in 2027, and until their respective successors have been duly elected and qualified. NOMINEE Votes FOR Votes WITHHELD Broker Non-Votes Jeffrey G. Park 187,019,809 5,042,225 8,678,306 Thomas E. Price, M.D. 188,324,272 3,737,762 8,678,306 Mary Tolan 189,438,931 2,623,103 8,678,306 Proposal 2 — Ratification of the appointment of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 200,600,987 110,133 29,220 — Proposal 3 — Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 191,518,133 293,863 250,038 8,678,306 Proposal 4 — Approval, on an advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers. Votes ONE YEAR Votes TWO YEARS Votes THREE YEARS Votes ABSTAINED 166,276,012 26,544 25,539,688 219,790 Based on the foregoing votes, each of the three Class III director nominees were elected, Proposals 2 and 3 were approved, and "ONE YEAR" was approved as the frequency of fu

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. P3 Health Partners Inc. Date: June 7, 2024 By: /s/ Atul Kavthekar Name: Atul Kavthekar Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR